You could call L cells a GLP-1 factory. The major difference between the GLP-1 you take via medication versus that in food is how long it lasts in the body
Pathogenic and non-pathogenic
In another study, interleukin-6 levels were elevated in the fat from women with Dercum disease compared to women without lipedema supporting Dercum disease as an inflammatory disorder (226)
Although the regulatory mechanism of autophagy by most immune-related signaling molecules is currently unknown, some findings provide clues
#SkinCore #SkinCorePH | SkinCore
National Library of Medicine , "FDA Approves Ozempic (Semaglutide) as the Only GLP-1 RA to Reduce the Risk of Worsening Kidney Disease and Cardiovascular Death in Adults with Type 2 Diabetes and Chronic Kidney Disease." PR Newswire , "FDA Approves Wegovy (Semaglutide) for Adults with Obesity." Drugs.com , 2021, Fonseca, Vivian A., et al